✦ LIBER ✦

8038 Oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) in primary or recurrent epithelial ovarian cancer: a pilot study of 31 patients

✍ Scribed by Frenel, J.S.; Classe, J.M.; Dravet, F.; Leux, C.; Rigaud, D. Berton; Bourbouloux, E.

Book ID: 122807536
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71560-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin-based hyperthermic intraperi

Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients

✍ Jean-Sebastien Frenel; Christophe Leux; Luc Pouplin; Gwenael Ferron; Dominique B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Hyperthermic Intraperitoneal Chemotherap

Hyperthermic Intraperitoneal Chemotherapy After Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study

✍ Myong Cheol Lim; Sokbom Kang; Jaeho Choi; Yong Jung Song; Sohee Park; Sang-Soo S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 230 KB

Hyperthermic intraperitoneal chemotherap

Hyperthermic intraperitoneal chemotherapy following extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: Result of a prospective phase II study

✍ Lim, M.; Im, M.; Yoo, H.; Seo, S.; Kang, S.; Park, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Role of salvage chemotherapy with topote

Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel- and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study

✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth